Amicus Therapeutics, Inc. earnings per share and revenue

FOLD earnings per share for the last quarter are 0.05 USD whereas the estimation was 0.01 USD which accounts for 301.64% surprise. Company revenue for the same period amounts to 149.71 M USD despite the estimated figure of 147.87 M USD. Estimated earnings per share for the next quarter are -0.05 USD, and revenue is expected to reach 136.65 M USD. Also watch annual changes over time to get a bigger picture of FOLD earnings per share and revenue dynamics.